Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates
Saved in:
| Main Authors: | Yu-Ying Shi, Gang Fan, Ruirong Tan, Shan Li, Hua-Bing Sun, Rui Li, Mengni Yang, Shanshan Gao, Miao Liu, Meng-Yuan Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-11-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-024-07182-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates
by: Yu-Ying Shi, et al.
Published: (2024-09-01) -
Targeted degradation of cell surface proteins through endocytosis triggered by cell-penetrating peptide-small molecule conjugates
by: Wanyi He, et al.
Published: (2025-08-01) -
Interaction mechanism of Soil-ICB Grid
by: Islam Elkorashi, et al.
Published: (2022-06-01) -
A proximity-induced chimera platform for targeted protein arginine methylation
by: Yanlin Jian, et al.
Published: (2025-05-01) -
Design and verification of a DMA controller based on the ICB bus
by: Su Xing, et al.
Published: (2024-01-01)